The global transcutaneous monitor market is experiencing steady growth, driven by increasing demand for non-invasive patient monitoring technologies, rising neonatal care requirements, and advancements in medical devices. According to Fortune Business Insights, the global transcutaneous monitor market size was valued at USD 299.91 million in 2025 and is projected to grow from USD 323.09 million in 2026 to USD 586.17 million by 2034, exhibiting a CAGR of 7.73% during the forecast period.
As healthcare providers prioritize accurate, continuous, and minimally invasive monitoring solutions, transcutaneous monitors are becoming an essential component of critical care, neonatal intensive care units (NICUs), and respiratory medicine.
A transcutaneous monitor is a medical device used to measure the partial pressure of oxygen (TcPO₂) and carbon dioxide (TcPCO₂) through the skin without drawing blood. The device uses heated sensors placed on the skin to provide continuous real-time measurements of a patient's respiratory status.
These monitors are widely used for:
By reducing the need for frequent arterial blood sampling, transcutaneous monitors improve patient comfort while enabling continuous monitoring.
Healthcare providers are increasingly adopting non-invasive monitoring technologies that minimize patient discomfort while delivering accurate physiological data. Transcutaneous monitors eliminate the need for repeated blood gas analysis, making them particularly valuable in neonatal and intensive care settings.
The growing number of premature births worldwide has significantly increased demand for neonatal monitoring equipment. Continuous monitoring of oxygen and carbon dioxide levels is essential for managing respiratory complications in newborns.
The rising prevalence of chronic respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea is driving demand for advanced monitoring solutions that support early diagnosis and effective treatment.